Bioprocess Development Forum - Insights, Solutions, and Shortcuts in Bioprocessing
BioPharm
Sponsored by Cytiva
Biopharma Trends
Upstream
Downstream
Regulatory/QbD
Articles
Subscribe to Enews
Share This Page
Email
Facebook
Twitter
March 24, 2022
mRNA vaccines: current trends and perspectives
Cytiva
The promise and challenges of mRNA vaccine development.
READ MORE >>
Related Content
Process Development challenges for mRNA vaccines and beyond
Discussing the Origins of the mRNA Therapeutics Field
How can you harness the potential of nucleic acid therapeutics?
mRNA Therapeutics and Vaccines – Key Process Considerations
Cytiva to provide Arranta Bio 'idea to injection' solutions for integrated manufacturing of mRNA products
See All Articles…
